Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...

GRAND JUNCTION, Colo. (KJCT) - More than 60% of people diagnosed with lung cancers are non-smokers, despite the disease’s ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

A 69-year-old Greeley woman had just hiked 8 miles in Sedona, Arizona, when she received a call that she had lung cancer. Despite her active lifestyle, a past of smoking crept up on her without any ...

Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease ...

Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has progressed after chemotherapy and immunotherapy.

University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...

A retrospective study finds that more than one third of patients with stage I-IIIA non-small cell lung cancer do not undergo ...

Shame can shape how early patients get diagnosed, and how aggressively they pursue treatment, if at all. In a 2014 study, Dr. Carter-Bawa found that lung cancer stigma was tied to patients waiting ...

When appropriate, surgery remains the most effective treatment option for non-small cell lung cancer (NSCLC), including for patients with COPD, said Friedberg, professor in the Department of Thoracic ...

For November's Lung Cancer Awareness Month, survivor Dusty Donaldson, 71, has been meeting with patients, researchers and fellow advocates across the country LiveLung Dusty Donaldson, a lung cancer ...